- Home
- RGNX vs NBN Comparison
RGNX vs NBN Comparison
Compare RGNX & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGNX | NBN |
|---|---|---|
| Founded | 2008 | 1872 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.0M | 836.7M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | RGNX | NBN |
|---|---|---|
| Price | $14.31 | $104.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | $30.78 | ★ $102.00 |
| AVG Volume (30 Days) | ★ 662.8K | 107.4K |
| Earning Date | 11-06-2025 | 02-05-2026 |
| Dividend Yield | N/A | ★ 0.04% |
| EPS Growth | N/A | ★ 38.19 |
| EPS | N/A | ★ 10.63 |
| Revenue | $161,318,000.00 | ★ $214,699,000.00 |
| Revenue This Year | $132.80 | $11.59 |
| Revenue Next Year | $45.32 | $11.26 |
| P/E Ratio | ★ N/A | $9.78 |
| Revenue Growth | ★ 91.30 | 36.17 |
| 52 Week Low | $5.04 | $78.17 |
| 52 Week High | $15.41 | $113.01 |
Technical Indicators
Market Signals| Indicator | RGNX | NBN |
|---|---|---|
| Relative Strength Index (RSI) | 57.97 | 63.03 |
| Support Level | $13.66 | $102.98 |
| Resistance Level | $15.41 | $108.15 |
| Average True Range (ATR) | 0.89 | 3.00 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 60.66 | 51.41 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About NBN Northeast Bank
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.